BX Swiss TOP 30 CHF
1.372,35
PKT
-16,20
PKT
-1,17
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.12.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 05.12.23 | Roche Sell | Deutsche Bank AG | |
| 05.12.23 | Swiss Re Sector Perform | RBC Capital Markets | |
| 05.12.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 05.12.23 | Richemont Sector Perform | RBC Capital Markets | |
| 05.12.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.12.23 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.12.23 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.12.23 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 04.12.23 | Swiss Re Halten | DZ BANK | |
| 04.12.23 | Swiss Re Equal Weight | Barclays Capital | |
| 04.12.23 | Roche Neutral | UBS AG | |
| 04.12.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 04.12.23 | Roche Hold | Jefferies & Company Inc. | |
| 01.12.23 | Roche Sell | Deutsche Bank AG | |
| 01.12.23 | Swiss Re Hold | Jefferies & Company Inc. | |
| 01.12.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 01.12.23 | Swiss Re Sell | UBS AG | |
| 01.12.23 | Richemont Outperform | Bernstein Research | |
| 01.12.23 | UBS Buy | Goldman Sachs Group Inc. | |
| 30.11.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 30.11.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 30.11.23 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 30.11.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 30.11.23 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 30.11.23 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 30.11.23 | Richemont Overweight | Barclays Capital | |
| 30.11.23 | UBS Overweight | JP Morgan Chase & Co. | |
| 30.11.23 | Richemont Buy | Deutsche Bank AG | |
| 30.11.23 | Novartis Buy | Deutsche Bank AG | |
| 30.11.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 29.11.23 | Novartis Underweight | Barclays Capital | |
| 29.11.23 | Richemont Sector Perform | RBC Capital Markets | |
| 29.11.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 29.11.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 29.11.23 | Swiss Re Hold | Deutsche Bank AG | |
| 29.11.23 | Zurich Insurance Hold | Deutsche Bank AG | |
| 28.11.23 | Nestlé Overweight | Barclays Capital | |
| 28.11.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 28.11.23 | Novartis Neutral | UBS AG |